Can-Fite Biopharma (CANF) Revenue (2010 - 2025)
Can-Fite Biopharma (CANF) revenue from Sep 30, 2010 to Jun 30, 2025. The TTM Can-Fite Biopharma (CANF) revenue is $560K. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Can-Fite Biopharma (CANF) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -17.65% |
| 3 Years TTM | -13.32% |
| 5 Years TTM | -20.29% |
| 10 Years TTM | +23.11% |
| All Time TTM | +0.40% |
Annual Revenue change of Can-Fite Biopharma (CANF)
| Year | Revenue | Change |
|---|---|---|
| 2025 | $410K | -38.81% |
| 2024 | $670K | -9.46% |
| 2023 | $740K | -8.64% |
| 2022 | $810K | -4.71% |
| 2021 | $850K | +11.84% |
| 2020 | $760K | -62.56% |
| 2019 | $2.03M | -46.86% |
| 2018 | $3.82M | +354.76% |
| 2017 | $840K | +394.12% |
| 2016 | $170K | +6.25% |
| 2015 | $160K | N/A |
| 2014 | $0 | -100.00% |
| 2013 | $1.79M | N/A |
| 2012 | $0 | -100.00% |
| 2011 | $470K | -37.33% |
| 2010 | $750K | N/A |
Comparison Can-Fite Biopharma (CANF) five years revenue CAGR with competitors
Can-Fite Biopharma (CANF) five years revenue CAGR is -20.34%.